Abstract
Purpose
The aim of this study was to compare the impact of fermented and unfermented soy intake, based on the following soy-derived products: tofu, soymilk, natto, and miso, on the risk of liver cancer among Japanese adults.
Methods
75,089 Participants of the Japan Public Health Center-based Prospective Study (JPHC Study) were followed from the time of the 5-year follow-up questionnaire until the end of 2012–2013. Subjects with available data on hepatitis B virus (HBV) and hepatitis C virus (HCV) infection status from blood samples (n = 14,016) and those who were anti-HCV antibody (anti-HCV) or hepatitis B virus antigen (HBsAg) positive (n = 1033) were also analyzed separately. Cox proportional hazard models were employed to calculate hazard ratios (HRs) and 95% confidence intervals (95% CIs).
Results
During 1,145,453 person-years, 534 newly diagnosed cases of liver cancer were identified in the JPHC Study. For miso intake among men, the multivariate-adjusted highest versus lowest quartile HR was 0.65 (95% CI, 0.48–0.89); p for trend = 0.006. Results were similar in those who were anti-HCV or HBsAg positive, 0.24 (0.08–0.70); p for trend = 0.004 highest versus lowest tertile. For the sub-analysis among only participants with known hepatitis infection status and HCV and HBsAg adjustment, a similar association was observed. In the multivariate complete cohort analysis, among women, the highest intake of fried tofu was inversely associated with the risk of liver cancer, HR = 0.45 (0.26–0.80); p for trend = 0.014.
Conclusions
We observed no association between total soy intake, fermented and unfermented, and risk of liver cancer, and only an inverse association between miso intake and liver cancer among men.
Similar content being viewed by others
Abbreviations
- 95% CI:
-
95% Confidence intervals
- Anti-HCV:
-
Anti-HCV antibody
- BMI:
-
Body mass index
- DCO:
-
Death certificate only
- FFQ:
-
Food frequency questionnaire
- HBV:
-
Hepatitis B virus
- HBsAg:
-
Hepatitis B virus antigen
- HCC:
-
Hepatocellular carcinoma
- HCV:
-
Hepatitis C virus
- HR:
-
Hazard ratio
- JPHC Study:
-
Japan Public Health Center-based Prospective Study
- PHC:
-
Public health center
- R-PHA:
-
Passive hemagglutination
- anti-HBc:
-
Hepatitis B core antigen
References
Lee GA, Crawford GW, Liu L, Sasaki Y, Chen XX (2011) Archaeological Soybean (Glycine max) in East Asia: does size matter? PLoS ONE 6(11):e26720. https://doi.org/10.1371/journal.pone.0026720
Salgado JM, Donado-Pestana CM (2011) Soy as a functional food. In: El-Shemy PH (ed) Soybean and nutrition. InTech
Dong JY, Qin LQ (2011) Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 125(2):315–323. https://doi.org/10.1007/s10549-010-1270-8
Martinez-Montemayor MM, Otero-Franqui E, Martinez J, De La Mota-Peynado A, Cubano LA, Dharmawardhane S (2010) Individual and combined soy isoflavones exert differential effects on metastatic cancer progression. Clin Exp Metastasis 27(7):465–480. https://doi.org/10.1007/s10585-010-9336-x
Guo Y, Wang S, Hoot DR, Clinton SK (2007) Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. J Nutr Biochem 18(6):408–417. https://doi.org/10.1016/j.jnutbio.2006.08.006
Kerwin SM (2004) Soy saponins and the anticancer effects of soybeans and soy-based foods. Curr Med Chem Anticancer Agents 4(3):263–272
Rao AV, Sung MK (1995) Saponins as anticarcinogens. J Nutr 125(3):S717–S724
Kang J, Badger TM, Ronis MJ, Wu X (2010) Non-isoflavone phytochemicals in soy and their health effects. J Agric Food Chem 58(14):8119–8133. https://doi.org/10.1021/jf100901b
Raju J, Mehta R (2009) Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin. Nutr Cancer 61(1):27–35. https://doi.org/10.1080/01635580802357352
Adami H-O, Hunter DJ, Trichopoulos D (2008) Textbook of cancer epidemiology, 2nd edn. Oxford University Press, Oxford
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. In: International Agency for Research on Cancer, Lyon, France
Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev 25(1):16–27. https://doi.org/10.1158/1055-9965.EPI-15-0578
The Editorial Board of the Cancer Statistics in Japan (2018) Cancer Statistics in Japan 2017. In: Foundation for Promotion of Cancer Research, Tokyo, Japan
Yan L, Spitznagel EL (2009) Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 89(4):1155–1163. https://doi.org/10.3945/ajcn.2008.27029
Kim J, Kang M, Lee JS, Inoue M, Sasazuki S, Tsugane S (2011) Fermented and non-fermented soy food consumption and gastric cancer in Japanese and Korean populations: a meta-analysis of observational studies. Cancer Sci 102(1):231–244. https://doi.org/10.1111/j.1349-7006.2010.01770.x
Lei B, Roncaglia V, Vigano R, Cremonini C, De Maria N, Del Buono MG et al (2002) Phytoestrogens and liver disease. Mol Cell Endocrinol 193(1–2):81–84
Kurahashi N, Inoue M, Iwasaki M, Tanaka Y, Mizokami M, Tsugane S et al (2009) Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population-based prospective cohort of Japanese men and women. Int J Cancer 124(7):1644–1649. https://doi.org/10.1002/ijc.24121
Hirayama T (1989) A large-scale cohort study on risk factors for primary liver cancer, with special reference to the role of cigarette smoking. Cancer Chemother Pharmacol 23(Suppl):S114–117
Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H et al (2004) Dietary habits and risk of death due to hepatocellular carcinoma in a large scale cohort study in Japan. Univariate analysis of JACC study data. Kurume Med J 51(2):141–149
Fukuda K, Shibata A, Hirohata I, Tanikawa K, Yamaguchi G, Ishii M (1993) A hospital-based case–control study on hepatocellular carcinoma in Fukuoka and Saga Prefectures, northern Kyushu, Japan. Jpn J Cancer Res 84(7):708–714
Sharp GB, Lagarde F, Mizuno T, Sauvaget C, Fukuhara T, Allen N et al (2005) Relationship of hepatocellular carcinoma to soya food consumption: a cohort-based, case–control study in Japan. Int J Cancer 115(2):290–295. https://doi.org/10.1002/ijc.20897
Katagiri R, Sawada N, Goto A, Yamaji T, Iwasaki M, Noda M et al (2020) Association of soy and fermented soy product intake with total and cause specific mortality: prospective cohort study. BMJ 368:m34. https://doi.org/10.1136/bmj.m34
Wu AH, Yang D, Pike MC (2000) A meta-analysis of soyfoods and risk of stomach cancer: the problem of potential confounders. Cancer Epidemiol Biomarkers Prev 9(10):1051–1058
Hutchins AM, Slavin JL, Lampe JW (1995) Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J Am Diet Assoc 95(5):545–551. https://doi.org/10.1016/S0002-8223(95)00149-2
Watanabe H (2013) Beneficial biological effects of miso with reference to radiation injury, cancer and hypertension. J Toxicol Pathol 26(2):91–103. https://doi.org/10.1293/tox.26.91
Tsugane S, Sawada N (2014) The JPHC Study: design and some findings on the typical Japanese diet. Jpn J Clin Oncol 44(9):777–782. https://doi.org/10.1093/jjco/hyu096
Abe SK, Inoue M, Sawada N, Iwasaki M, Shimazu T, Yamaji T et al (2015) Hepatitis B and C virus infection and risk of lymphoid malignancies: a population-based cohort study (JPHC Study). Cancer Epidemiol 39(4):562–566. https://doi.org/10.1016/j.canep.2015.06.002
Ishihara J, Inoue M, Kobayashi M, Tanaka S, Yamamoto S, Iso H et al (2006) Impact of the revision of a nutrient database on the validity of a self-administered food frequency questionnaire (FFQ). J Epidemiol Jpn Epidemiolog Assoc 16(3):107–116
Ishihara J, Sobue T, Yamamoto S, Yoshimi I, Sasaki S, Kobayashi M et al (2003) Validity and reproducibility of a self-administered food frequency questionnaire in the JPHC Study cohort II: study design, participant profile and results in comparison with cohort I. J Epidemiol Jpn Epidemiolog Assoc 13(1 Suppl):S134–147
Sasaki S, Takahashi T, Iitoi Y, Iwase Y, Kobayashi M, Ishihara J et al (2003) Food and nutrient intakes assessed with dietary records for the validation study of a self-administered food frequency questionnaire in JPHC Study cohort I. J Epidemiol Jpn Epidemiolog Assoc 13(1 Suppl):S23–50
Nozue M, Shimazu T, Sasazuki S, Charvat H, Mori N, Mutoh M et al (2017) Fermented soy product intake is inversely associated with the development of high blood pressure: the Japan public health center-based prospective study. J Nutr 147(9):1749–1756. https://doi.org/10.3945/jn.117.250282
Michikawa T, Inoue M, Sawada N, Tanaka Y, Yamaji T, Iwasaki M et al (2015) Plasma isoflavones and risk of primary liver cancer in Japanese women and men with hepatitis virus infection: a nested case–control study. Cancer Epidemiol Biomarkers Prev 24(3):532–537. https://doi.org/10.1158/1055-9965.EPI-14-1118
World Health Organization (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneve (Switzerland)
Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65(4 Suppl): 1220S–1228S (discussion 1229S-1231S)
Inoue M, Yoshimi I, Sobue T, Tsugane S, Group JS (2005) Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 97(4):293–300. https://doi.org/10.1093/jnci/dji040
Tsugane S, Inoue M (2010) Insulin resistance and cancer: epidemiological evidence. Cancer Sci 101(5):1073–1079. https://doi.org/10.1111/j.1349-7006.2010.01521.x
WCRF (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington
Chen Y, Wang X, Wang J, Yan Z, Luo J (2012) Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer 48(14):2137–2145. https://doi.org/10.1016/j.ejca.2012.02.063
Lee YC, Cohet C, Yang YC, Stayner L, Hashibe M, Straif K (2009) Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol 38(6):1497–1511. https://doi.org/10.1093/ije/dyp280
Sawada N, Inoue M, Iwasaki M, Sasazuki S, Shimazu T, Yamaji T et al (2012) Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma. Gastroenterology 142(7):1468–1475. https://doi.org/10.1053/j.gastro.2012.02.018
Brady CW (2015) Liver disease in menopause. World J Gastroenterol 21(25):7613–7620. https://doi.org/10.3748/wjg.v21.i25.7613
Paredes-Lopez O, Guevara-Lara F, Schevenin-Pinedo ML, Montes-Rivera R (1989) Comparison of procedures to determine protein content of developing bean seeds (Phaseolus vulgaris). Plant Foods Hum Nutr 39(2):137–148
Nnam NM (1995) Evaluation of nutritional quality of fermented cowpea (Vigna-Unguiculata) flours. Ecol Food Nutr 33(4):273–279. https://doi.org/10.1080/03670244.1995.9991435
Ibrahim SS, Habiba RA, Shatta AA, Embaby HE (2002) Effect of soaking, germination, cooking and fermentation on antinutritional factors in cowpeas. Nahrung 46(2):92–95. https://doi.org/10.1002/1521-3803(20020301)46:2<92:Aid-Food92>3.0.Co;2-P
Rodríguez-Bürger AP, Mason A, Nielsen SS (1998) Use of fermented black beans combined with rice to develop a nutritious weaning food. J Agri Food Chem 46(12):4806–4813. https://doi.org/10.1021/jf980674h
Boye J, Ribéreau S (2011) Assessing compositional differences in soy products and impacts on health claims, soybean and nutrition. In: El-Shemy PH (ed) Soybean and nutrition. InTech, Available from: https://www.intechopen.com/books/soybean-and-nutrition/assessing-compositional-differencesin-soy-products-and-impacts-on-health-claims
Snyder HE, Kwon TW (1987) Soybean utilization. Springer, The Netherlands
Kitagawa I, Yoshikawa M, Hayashi T, Taniyama T (1984) Quantitative determination of soyasaponins in soybeans of various origins and soybean products by means of high performance liquid chromatography. Yakugaku Zasshi J Pharmaceut Soc Jpn 104(3):275–279
Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S, Japan Public Health Center-Based Prospective Study on Cancer Cardiovascular Diseases G (2003) Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst 95(12):906–913
Funding
This study was supported by the National Cancer Center Research and Development Fund (29-A-4, 26-A-2, 23-A-31 [toku]) (since 2011), a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare in Japan (from 1989 to 2010), and a grant from the Ministry of Agriculture, Fishery and Forestry of Japan (MAFF-CPS-2016-1-1). No relevant conflicts of interest exist.
Author information
Authors and Affiliations
Consortia
Contributions
MI* designed the study and checked the paper for consistency. SKA analyzed the data, generated the tables, and drafted the manuscript. NM, JI, and RT helped with the nutritional aspects of the study. NS, TY, TS, AG, MI*, MI, and ST substantially contributed to the interpretation of the results.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no potential financial, personal, or other conflicts of interests.
Additional information
Research group members are listed at the following site (as of May, 2019): https://epi.ncc.go.jp/en/jphc/781/8233.html
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Abe, S.K., Sawada, N., Ishihara, J. et al. Comparison between the impact of fermented and unfermented soy intake on the risk of liver cancer: the JPHC Study. Eur J Nutr 60, 1389–1401 (2021). https://doi.org/10.1007/s00394-020-02335-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-020-02335-9